Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832

Watchlist Manager
Shenzhen New Industries Biomedical Engineering Co Ltd Logo
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Watchlist
Price: 51.27 CNY 0.08% Market Closed
Market Cap: 40.3B CNY

Intrinsic Value

The intrinsic value of one Shenzhen New Industries Biomedical Engineering Co Ltd stock under the Base Case scenario is 79.6 CNY. Compared to the current market price of 51.27 CNY, Shenzhen New Industries Biomedical Engineering Co Ltd is Undervalued by 36%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
79.6 CNY
Undervaluation 36%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Shenzhen New Industries Biomedical Engineering Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Shenzhen New Industries Biomedical Engineering Co Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Shenzhen New Industries Biomedical Engineering Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
CN
Health Care
Market Cap
40.3B CNY
IPO
May 12, 2020
CN
Health Care
Market Cap
40.3B CNY
IPO
May 12, 2020
Price
ÂĄfalse
EPS
ÂĄfalse
Shenzhen New Industries Biomedical Engineering Co Ltd
Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Shenzhen New Industries Biomedical Engineering Co Ltd?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Shenzhen New Industries Biomedical Engineering Co Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Shenzhen New Industries Biomedical Engineering Co Ltd

Current Assets 4.7B
Cash & Short-Term Investments 2.6B
Receivables 915.8m
Other Current Assets 1.2B
Non-Current Assets 4.2B
Long-Term Investments 1.9B
PP&E 1.5B
Intangibles 246.3m
Other Non-Current Assets 509.8m
Efficiency

Free Cash Flow Analysis
Shenzhen New Industries Biomedical Engineering Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Shenzhen New Industries Biomedical Engineering Co Ltd

Revenue
4.4B CNY
Cost of Revenue
-1.2B CNY
Gross Profit
3.2B CNY
Operating Expenses
-1.2B CNY
Operating Income
2B CNY
Other Expenses
-164.7m CNY
Net Income
1.9B CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Shenzhen New Industries Biomedical Engineering Co Ltd's profitability score is 76/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Positive Gross Profit
Positive Free Cash Flow
Positive Operating Income
76/100
Profitability
Score

Shenzhen New Industries Biomedical Engineering Co Ltd's profitability score is 76/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Shenzhen New Industries Biomedical Engineering Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

Shenzhen New Industries Biomedical Engineering Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Shenzhen New Industries Biomedical Engineering Co Ltd

Wall Street analysts forecast Shenzhen New Industries Biomedical Engineering Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shenzhen New Industries Biomedical Engineering Co Ltd is 86.27 CNY with a low forecast of 77.44 CNY and a high forecast of 95.55 CNY.

Lowest
Price Target
77.44 CNY
51% Upside
Average
Price Target
86.27 CNY
68% Upside
Highest
Price Target
95.55 CNY
86% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Shenzhen New Industries Biomedical Engineering Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one Shenzhen New Industries Biomedical Engineering Co Ltd stock?

The intrinsic value of one Shenzhen New Industries Biomedical Engineering Co Ltd stock under the Base Case scenario is 79.6 CNY.

Is Shenzhen New Industries Biomedical Engineering Co Ltd stock undervalued or overvalued?

Compared to the current market price of 51.27 CNY, Shenzhen New Industries Biomedical Engineering Co Ltd is Undervalued by 36%.

Back to Top